AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
ResMed Delivers Solid Performance Amidst Ongoing Market Leadership
April 28, 2025 09:31 PM AEST| By Team Kalkine MediaHighlights:,ResMed's third-quarter fiscal result showed steady growth despite typical seasonal challenges and currency fluctuations.,The company continues to expand its presence in the global obstructive sleep apnea market through innovative smart de...
ASX Healthcare Leader: ResMed’s Steady Growth in the OSA Market
April 28, 2025 08:53 PM AEST| By Team Kalkine MediaHighlights:,ResMed remains a dominant player in the global obstructive sleep apnea market, alongside Philips, with a strong presence in over 140 countries.,Third-quarter fiscal results showed positive growth despite typical seasonal challenges, with...
FDA Rejects Telix Pharmaceuticals' Glioma Imaging Agent Submission
April 28, 2025 05:36 PM AEST| By Team Kalkine MediaHighlights:,Telix Pharmaceuticals faces a setback as the FDA declines approval for its glioma imaging agent.,The regulatory body requests additional clinical evidence for the new drug application.,The decision does not affect Telix's financial outloo...
Cochlear Ltd (ASX:COH) Share Price Analysis in 2025
April 28, 2025 05:21 PM AEST| By Team Kalkine MediaHighlights:,Cochlear Ltd’s share price has decreased by approximately 7.5% since the start of 2025.,The company continues to lead in the global hearing device market with a broad international presence.,Currently, Cochlear Ltd shares are trading at a...
Radiopharm Theranostics (ASX:RAD) Advances Brain Metastasis Imaging with Promising Phase 2b Trial
April 28, 2025 03:45 PM AEST| By Team Kalkine MediaHighlights,Radiopharm Theranostics initiates Phase 2b trial for brain metastasis imaging.,18F-RAD101 targets fatty acid synthase for enhanced diagnostic precision.,Topline results expected in the second half of 2025.,Radiopharm Theranostics (ASX:RAD)...
EMVision dispatches its bedside brain scanning device to Mayo Clinic for evaluation at a second testing location.
April 28, 2025 01:31 PM AEST| By Team Kalkine MediaHighlights:,EMVision (ASX:EMV) enhances emergency care with bedside brain imaging technology.,Portable brain scanner aims to support first responders at incident sites.,Testing initiatives underway in leading US and Australian medical institutions.,T...
TrivarX Approved for US Trial to Use Heart Rate in Identifying Depression in Veterans
April 28, 2025 01:30 PM AEST| By Team Kalkine MediaHighlights:,TrivarX (ASX:TRI) initiates a trial using heart rate data to detect depression in US veterans.,The trial proceeds through collaboration with the Greater Los Angeles Veterans Research and Education Foundation and the US Department of Veter...
Pharmaceutical Sector: Telix Pharmaceuticals Addresses FDA Data Requirements for Imaging Agent
April 28, 2025 01:30 PM AEST| By Team Kalkine MediaHighlights:,Telix Pharmaceuticals faced an FDA request for additional data on TLX101-CDx.,TLX101-CDx holds Orphan Drug and Fast Track designations for glioma diagnosis.,Telix is advancing its clinical programs to meet regulatory requirements.,The pha...
ResMed (ASX:RMD): Why Healthcare Shares Continue to Win Investor Confidence
April 28, 2025 12:49 PM AEST| By Team Kalkine MediaHighlights,ResMed (RMD),operates,a global healthcare business with expanding digital health capabilities.,Healthcare sector’s 'sticky' revenue offers resilience during economic downturns.,Growth and sustainability trends are boosting healthcare inves...
Setback for Telix Pharmaceuticals (ASX:TLX) as FDA Requests Additional Data for Brain Cancer Imaging Agent
April 28, 2025 12:48 PM AEST| By Team Kalkine MediaHighlights,FDA issues complete response letter for TLX101-CDx application,No safety concerns raised for investigational brain cancer imaging agent,Telix,Pharmaceuticals to pursue,additional,clinical strategies for resubmission,Telix Pharmaceuticals (...
FDA Setback Hits Telix Pharmaceuticals' Imaging Agent Ambitions
April 28, 2025 12:44 PM AEST| By Team Kalkine MediaHighlights,Telix,Pharmaceuticals faces FDA roadblock for glioma imaging agent,Additional,clinical data,required,for TLX101-CDx approval,Company's financial guidance,remains,unaffected,Telix Pharmaceuticals (ASX:TLX) encountered a major hurdle after t...
Recce Pharmaceuticals Strengthens Biodefense Strategy with New US Army Research Agreement
April 28, 2025 11:55 AM AEST| By Team Kalkine MediaHighlights,Recce Pharmaceuticals advances partnership with US Army.,R327 to be tested against deadly pathogens under high biocontainment.,Collaboration boosts efforts to combat antimicrobial resistance.,Recce Pharmaceuticals (ASX:RCE) has taken a sig...
Telix Faces Regulatory Setback as FDA Requests More Data on Brain Cancer Imaging Agent
April 28, 2025 11:54 AM AEST| By Team Kalkine MediaHighlights,Telix,faces regulatory setback on brain cancer imaging agent,FDA requests more clinical evidence for approval,Company plans swift resubmission after addressing feedback,Shares of Telix Pharmaceuticals (ASX:TLX) fell nearly 6% on Monday aft...
SomnoMed Limited (ASX:SOM): A Comprehensive Look at Recent Performance
April 26, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights:,SomnoMed shares have seen a notable decline in recent weeks.,Despite recent challenges, the company has exhibited strong year-over-year growth.,The company's price-to-sales ratio reflects cautious investor sentiment.,SomnoMed Limited, lis...
Determining the Intrinsic Value of Alcidion Group Limited (ASX:ALC)
April 25, 2025 10:32 PM AEST| By Team Kalkine MediaHighlights:,Alcidion Group's share price closely reflects its estimated equity valuation derived from discounted cash flow modelling,The company maintains a debt-free structure with projected profitability supported by a strong cash position,Price-to...
Micro-X Insider Stock Buyers Recover Some Losses This Week
April 25, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights:,Micro-X insiders hold a significant stake in the company, with a substantial portion of shares owned by those directly involved.,A noteworthy acquisition by Chairman Patrick O'Brien highlights confidence in the company's future.,Insider t...
Recce Pharmaceuticals Prepares for Pivotal Trials with A$15.8 Million Funding Injection
April 24, 2025 07:00 PM AEST| By Team Kalkine MediaHighlights,Recce Pharmaceuticals secures A$15.8 million for pivotal Phase 3 trials.,Key focus on diabetic foot infections and skin infections across Asia-Pacific and Australia.,US clinical plans advance with FDA submission in view for late 2025.,Recc...
ResMed’s (ASX:RMD) Robust Growth Driven by Demand for Sleep Apnoea Solutions
April 24, 2025 06:44 PM AEST| By Team Kalkine MediaHighlights,ResMed delivers strong double-digit EPS growth.,Robust demand for sleep apnoea devices drives revenue.,New home-based diagnostic test expands patient access.,ResMed (ASX:RMD), a global leader in digital health and sleep technology, has rep...
ASX Healthcare Focus: Exploring Cochlear Ltd (ASX:COH) Amid Sector Trends
April 24, 2025 06:26 PM AEST| By Team Kalkine MediaHighlights:,Cochlear Ltd has recorded a share price decline since the beginning of the year,The company manufactures hearing implants and operates in over fifty countries,Broader ASX healthcare sector has seen muted returns over the past several year...
ResMed (ASX:RMD) Reports Strong FY25 Q3 Performance Driving Share Price Surge
April 24, 2025 06:17 PM AEST| By Team Kalkine MediaHighlights:,ResMed’s revenue increased driven by performance across all major markets and product segments,Net profit recorded double-digit growth supported by expanded gross margins,Gross profit margin improved due to product mix and operational eff...
Advertise your brand on Kalkine Media